Cargando…
Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3
BACKGROUND: MicroRNAs are small non-coding RNAs with pivotal regulatory functions in multiple cellular processes. Their significance as molecular predictors for breast cancer was demonstrated in the past 15 years. The aim of this study was to elucidate the role of hsa-miR-3651 for predicting of loca...
Autores principales: | Zellinger, Barbara, Bodenhofer, Ulrich, Engländer, Immanuela A., Kronberger, Cornelia, Grambozov, Brane, Ruznic, Elvis, Stana, Markus, Karner, Josef, Fastner, Gerd, Sotlar, Karl, Sedlmayer, Felix, Zehentmayr, Franz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885475/ https://www.ncbi.nlm.nih.gov/pubmed/34865205 http://dx.doi.org/10.1007/s12282-021-01308-y |
Ejemplares similares
-
Hsa-miR-375/RASD1 Signaling May Predict Local Control in Early Breast Cancer
por: Zellinger, Barbara, et al.
Publicado: (2020) -
High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC
por: Grambozov, Brane, et al.
Publicado: (2022) -
Carbon Monoxide Diffusing Capacity (DL(CO)) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III
por: Stana, Markus, et al.
Publicado: (2022) -
Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DL(CO) Correlate with Radiation Dosimetry and Pneumonitis Rate
por: Stana, Markus, et al.
Publicado: (2023) -
Impact of reirradiation, chemotherapy, and immunotherapy on survival of patients with recurrent lung cancer: A single‐center retrospective analysis
por: Grambozov, Brane, et al.
Publicado: (2021)